THE EFFECT OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL IN PATIENTS WITH RECURRENT HEAD AND NECK-CANCER

被引:3
|
作者
LINDELOV, B
HANSEN, HS
机构
关键词
D O I
10.3109/02841868909111252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:227 / 230
页数:4
相关论文
共 50 条
  • [21] Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer
    Janinis, J
    Papadakou, M
    Panagos, G
    Panousaki, A
    Georgoulias, V
    Hatzidaki, D
    Lefantzis, D
    Dokianakis, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 227 - 231
  • [22] CIS-PLATINUM AND 5-FLUOROURACIL AS INDUCTION THERAPY FOR ADVANCED HEAD AND NECK-CANCER
    WEAVER, A
    FLEMMING, S
    KISH, J
    VANDENBERG, H
    JACOB, J
    CRISSMAN, J
    ALSARRAF, M
    AMERICAN JOURNAL OF SURGERY, 1982, 144 (04): : 445 - 448
  • [23] SURVIVAL RESULTS FROM A PHASE-III STUDY OF SIMULTANEOUS VERSUS 1-HOUR SEQUENTIAL METHOTREXATE - 5-FLUOROURACIL CHEMOTHERAPY IN HEAD AND NECK-CANCER
    BROWMAN, GP
    LEVINE, MN
    RUSSELL, R
    YOUNG, JEM
    ARCHIBALD, SD
    HEAD & NECK SURGERY, 1986, 8 (03): : 146 - 152
  • [24] Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma
    Kushwaha, Vandana Singh
    Gupta, Seema
    Husain, Nuzhat
    Khan, Huma
    Negi, M. P. S.
    Jamal, Naseem
    Ghatak, Ashim
    CANCER BIOLOGY & THERAPY, 2015, 16 (02) : 346 - 351
  • [25] Concomitant radiotherapy, paclitaxel, 5-fluorouracil, and hydroxyurea in patients with advanced or recurrent head and neck cancer
    Haraf, DJ
    Stenson, K
    Witt, ME
    List, M
    Sulzen, L
    Weichselbaum, RR
    Vokes, EE
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (02) : S34 - S38
  • [26] METHOTREXATE (MTX), 5-FLUOROURACIL (FU) AND LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED HEAD AND NECK CANCER (HNC)
    OHNUMA, T
    COFFEY, V
    KOHNO, N
    BILLER, H
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 209 - 209
  • [27] CIS-DIAMMINODICHLOROPLATINUM PLUS A 5-DAY CONTINUOUS INFUSION OF 5-FLUOROURACIL IN THE TREATMENT OF LOCALLY RECURRENT AND METASTATIC HEAD AND NECK-CANCER PATIENTS
    PALMERI, S
    GEBBIA, V
    RUSSO, A
    GEBBIA, N
    OLIVERI, D
    RAUSA, L
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (06) : 579 - 582
  • [28] RESPONSE RATES AND SURVIVAL IN PATIENTS WITH HEAD AND NECK-CANCER TREATED WITH A COMBINATION OF CISPLATIN AND 5-FLUOROURACIL PRIOR TO RADIOTHERAPY
    THOMAS, GD
    PATERSON, ICM
    CLINICAL RADIOLOGY, 1988, 39 (05) : 551 - 554
  • [29] TREATMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA (RSCCHN) OF HEAD AND NECK WITH A SEQUENTIAL METHOTREXATE (MTX) 5-FLUOROURACIL (5-FU) REGIMEN
    SCHERLACHER, A
    JAKSE, R
    LEHNERT, M
    LARYNGOLOGIE RHINOLOGIE OTOLOGIE VEREINIGT MIT MONATSSCHRIFT FUR OHRENHEILKUNDE, 1985, 64 (02): : 58 - 61
  • [30] Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer
    Chang, Peter Mu-Hsin
    Teng, Hao-Wei
    Chen, Po-Min
    Chang, Shyue-Yih
    Chu, Pen-Yuan
    Tsai, Tung-Lung
    Tai, Shyh-Kuan
    Wang, Yi-Fen
    Huang, Jui-Lin
    Yang, Muh-Hwa
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2008, 71 (07) : 336 - 341